Similar Search Results

Income and the use of prescription drugs for near retirement individuals

Leth-Petersen, Søren; Skipper, Niels - In: Health economics 23 (2014) 3, pp. 314-331

Persistent link: https://www.econbiz.de/10010336528

The welfare impact of parallel imports : a structural approach applied to the German market for oral anti-diabetics

Duso, Tomaso; Herr, Annika; Suppliet, Moritz - 2014

We investigate the welfare impact of parallel imports using a large panel data set containing monthly information on sales, ex-factory prices, and further product characteristics for all 700 anti-diabetic drugs sold in Germany between 2004 and 2010. We estimate a two-stage nested logit model of...

Persistent link: https://www.econbiz.de/10010338113

The welfare impact of parallel imports : a structural approach applied to the German market for oral anti-diabetics

Duso, Tomaso; Herr, Annika; Suppliet, Moritz - 2014

Persistent link: https://www.econbiz.de/10010339071

Reference pricing and cost-sharing : theory and evidence on German off-patent drugs ; conference paper

Herr, Annika; Stühmeier, Torben; Wenzel, Tobias - 2014

-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference …

Persistent link: https://www.econbiz.de/10010489291

The welfare impact of parallel imports : a structural approach applied to the German market for oral antidiabetics ; conference paper

Duso, Tomaso; Herr, Annika; Suppliet, Moritz - 2014 - Preliminary version

We investigate the welfare impact of parallel imports using a large panel data set containing monthly information on sales, ex-factory prices, and further product characteristics for all 700 antidiabetic drugs sold in Germany between 2004 and 2010. We estimate a two-stage nested logit model of...

Persistent link: https://www.econbiz.de/10010481411

Does reference pricing drive out generic competition in pharmaceutical markets? : evidence from a policy reform

Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022

Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...

Persistent link: https://www.econbiz.de/10013285854

Trade in health products : reducing trade barriers for better health

Helble, Matthias; Shepherd, Benjamin - 2017

availability of health-related products such as pharmaceuticals, vaccines, and medical equipment. The case for liberalizing trade …

Persistent link: https://www.econbiz.de/10011591118

Parallel imports and manufacturer rebates : evidence from Germany

Birg, Laura - 2019

pharmaceuticals on competition by parallel imports. First, I analyze the effect of a manufacturer rebate on competition by parallel …

Persistent link: https://www.econbiz.de/10011949028

Chapter Twelve. Markets for Pharmaceutical Products

Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011

This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is …

Persistent link: https://www.econbiz.de/10014025576

Free Medicines Thanks to Retirement : Moral Hazard and Hospitalization Offsets in an NHS

Puig-Junoy, Jaume - 2011

Spain after retirement. To evaluate this coinsurance change we use a rich administrative dataset that links pharmaceutical … eligibility age for Social Security to control for the endogeneity of the retirement decision. Our most conservative results show …

Persistent link: https://www.econbiz.de/10013121905

1
2
3
4
5
6
7
8
9
10
Next
Last